We previously observed that members of the human epidermal growth factor receptor family, which are cell surface receptors, display a higher expression in aggressive tumors (carcinosarcoma) that overexpress versican in the stroma adjacent to the invasive areas, suggesting that the interaction between versican and these receptors may be directly associated with tumor aggressiveness [14]. Here, CD177 is linked to neoplasm.